HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Tao Lu Selected Research

Y-Box-Binding Protein 1

1/2020PRMT5-mediated methylation of YBX1 regulates NF-κB activity in colorectal cancer.
1/2017Novel Serine 176 Phosphorylation of YBX1 Activates NF-κB in Colon Cancer.
10/2015Critical role of phosphorylation of serine 165 of YBX1 on the activation of NF-κB in colon cancer.
9/2015Role of post-translational modification of the Y box binding protein 1 in human cancers.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Tao Lu Research Topics

Disease

128Neoplasms (Cancer)
12/2022 - 09/2002
13Colorectal Neoplasms (Colorectal Cancer)
10/2022 - 04/2016
13Neoplasm Metastasis (Metastasis)
07/2022 - 01/2012
11Inflammation (Inflammations)
03/2022 - 03/2007
10Melanoma (Melanoma, Malignant)
12/2022 - 01/2006
10Infections
07/2022 - 09/2009
9Carcinoma (Carcinomatosis)
01/2021 - 03/2004
9Carcinogenesis
11/2020 - 09/2004
8Adenocarcinoma of Lung
06/2022 - 01/2019
8Lung Neoplasms (Lung Cancer)
02/2022 - 01/2014
8Alzheimer Disease (Alzheimer's Disease)
01/2022 - 01/2008
7Breast Neoplasms (Breast Cancer)
03/2022 - 11/2017
6Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
07/2022 - 01/2014
6Hepatocellular Carcinoma (Hepatoma)
06/2021 - 04/2015
5COVID-19
04/2022 - 01/2020
5Neurodegenerative Diseases (Neurodegenerative Disease)
01/2022 - 08/2010
5Body Weight (Weight, Body)
02/2021 - 01/2015
5Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
01/2021 - 01/2018
4Stroke (Strokes)
07/2022 - 03/2018
4Obesity
05/2022 - 01/2019
4Autoimmune Diseases (Autoimmune Disease)
01/2022 - 03/2011
4Hypoxia (Hypoxemia)
01/2022 - 10/2014
4Ovarian Neoplasms (Ovarian Cancer)
03/2021 - 07/2014
4Parkinson Disease (Parkinson's Disease)
12/2020 - 01/2008
4Prostatic Neoplasms (Prostate Cancer)
11/2020 - 05/2004
3Dementia (Dementias)
07/2022 - 01/2014
3Ischemic Stroke
07/2022 - 03/2018
3Cerebral Infarction
07/2022 - 01/2019
3Squamous Cell Carcinoma (Epidermoid Carcinoma)
01/2022 - 01/2020
3Rheumatoid Arthritis
01/2022 - 08/2012
3Necrosis
10/2021 - 02/2011
3Pancreatic Neoplasms (Pancreatic Cancer)
04/2021 - 01/2018
3Papillary Thyroid Cancer
12/2019 - 01/2015
3Wounds and Injuries (Trauma)
06/2019 - 08/2012
3Edema (Dropsy)
03/2019 - 09/2010
3Colonic Neoplasms (Colon Cancer)
01/2017 - 10/2015
3Ischemia
12/2013 - 01/2004
2Cognitive Dysfunction
04/2022 - 01/2022
2Asthma (Bronchial Asthma)
03/2022 - 01/2017
2Thyroid Neoplasms (Thyroid Cancer)
03/2022 - 03/2017

Drug/Important Bio-Agent (IBA)

31Proteins (Proteins, Gene)FDA Link
10/2022 - 04/2003
30Pharmaceutical PreparationsIBA
08/2022 - 04/2011
17Biomarkers (Surrogate Marker)IBA
04/2022 - 09/2002
13Phosphotransferases (Kinase)IBA
12/2020 - 05/2010
12Transcription Factors (Transcription Factor)IBA
07/2022 - 09/2004
9CytokinesIBA
01/2020 - 03/2004
8RNA (Ribonucleic Acid)IBA
01/2022 - 09/2018
7Long Noncoding RNAIBA
01/2022 - 12/2016
7DNA (Deoxyribonucleic Acid)IBA
01/2021 - 07/2004
6Histone Deacetylases (Histone Deacetylase)IBA
08/2022 - 01/2016
6Anti-Bacterial Agents (Antibiotics)IBA
07/2022 - 02/2016
5Therapeutic UsesIBA
07/2022 - 01/2020
5Glucose (Dextrose)FDA LinkGeneric
12/2021 - 01/2004
5NF-kappa B (NF-kB)IBA
01/2021 - 03/2004
5Small Interfering RNA (siRNA)IBA
11/2020 - 04/2003
4Histone Deacetylase InhibitorsIBA
10/2022 - 01/2019
4Indicators and Reagents (Reagents)IBA
01/2022 - 06/2019
4Matrix Metalloproteinases (MMPs)IBA
01/2022 - 04/2015
4Small Cytoplasmic RNAIBA
07/2021 - 01/2020
4MicroRNAs (MicroRNA)IBA
06/2021 - 01/2019
4fms-Like Tyrosine Kinase 3IBA
01/2021 - 01/2018
4Biological ProductsIBA
01/2021 - 03/2007
4EnzymesIBA
11/2020 - 08/2013
4Y-Box-Binding Protein 1IBA
01/2020 - 09/2015
4Protein Kinases (Protein Kinase)IBA
04/2016 - 12/2013
4Beclin-1IBA
10/2014 - 05/2006
3Peptides (Polypeptides)IBA
12/2022 - 01/2017
3Messenger RNA (mRNA)IBA
01/2022 - 02/2019
3ElementsIBA
01/2022 - 04/2003
3Transforming Growth Factors (Transforming Growth Factor)IBA
12/2021 - 09/2010
3Tyrosine Kinase InhibitorsIBA
06/2021 - 01/2015
3Sorafenib (BAY 43-9006)FDA Link
01/2021 - 01/2015
3MicellesIBA
01/2021 - 01/2019
3ParaffinIBA
12/2020 - 09/2012
3ErbB Receptors (EGF Receptor)IBA
12/2020 - 01/2015
3Histones (Histone)IBA
11/2020 - 03/2011
3Lysine (L-Lysine)FDA Link
11/2020 - 03/2011
3Interleukin-6 (Interleukin 6)IBA
09/2020 - 01/2019
3Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA
06/2020 - 10/2015
3Serine (L-Serine)FDA Link
05/2020 - 10/2015
3VemurafenibIBA
02/2019 - 01/2015
3Antineoplastic Agents (Antineoplastics)IBA
01/2018 - 06/2017
3IronIBA
11/2017 - 05/2009
3Cadherins (E-Cadherin)IBA
12/2016 - 05/2009
3Amyloid beta-PeptidesIBA
08/2010 - 01/2008
2EstersIBA
12/2022 - 12/2020
2AntigensIBA
12/2022 - 01/2018
2TIC10 compoundIBA
10/2022 - 08/2022
2Proton Pump InhibitorsIBA
07/2022 - 04/2016
2Metformin (Glucophage)FDA LinkGeneric
07/2022 - 05/2022
2Pemetrexed (MTA)FDA Link
06/2022 - 12/2019
2CateninsIBA
06/2022 - 05/2009
2Telomerase (Telomerase Reverse Transcriptase)IBA
03/2022 - 01/2020

Therapy/Procedure

38Therapeutics
07/2022 - 05/2012
15Drug Therapy (Chemotherapy)
02/2022 - 03/2004
6Radiotherapy
01/2020 - 01/2018
4Immunotherapy
12/2022 - 01/2020
3Chinese Traditional Medicine (Traditional Chinese Medicine)
01/2022 - 01/2020
3Neoadjuvant Therapy
01/2021 - 01/2018
3Oral Administration
01/2020 - 04/2015